Basit öğe kaydını göster

dc.contributor.authorKonukoglu, Dihlar
dc.contributor.authorSENYIGIT, Abdulhalim
dc.contributor.authorUgurlu, Serdal
dc.contributor.authorTabak, Omur
dc.contributor.authorUzun, Hafize
dc.contributor.authorORBANOGLU, Timur
dc.contributor.authorKaradag, Aytac
dc.date.accessioned2021-03-06T10:53:05Z
dc.date.available2021-03-06T10:53:05Z
dc.date.issued2017
dc.identifier.citationSENYIGIT A., Tabak O., ORBANOGLU T., Karadag A., Ugurlu S., Uzun H., Konukoglu D., "Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes", CLINICAL AND INVESTIGATIVE MEDICINE, cilt.40, 2017
dc.identifier.issn0147-958X
dc.identifier.othervv_1032021
dc.identifier.otherav_ec79eaca-9133-4191-bf7c-261474861c13
dc.identifier.urihttp://hdl.handle.net/20.500.12627/155262
dc.identifier.urihttps://doi.org/10.25011/cim.v40i5.28624
dc.description.abstractPurpose: Hyperglycemia is the major risk factor for microvascular complications in type 2 diabetes mellitus (T2DM) patients. This randomized controlled clinical trial aimed to investigate T2DM patients with microvascular complications with regard to possible relations among serum clusterin (CLU), amylin, secreted frizzled-related protein-4 (SFRP-4), glucagon-like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP-4) activities.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectDahili Tıp Bilimleri
dc.titleGlucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes
dc.typeMakale
dc.relation.journalCLINICAL AND INVESTIGATIVE MEDICINE
dc.contributor.departmentUniv Biruni , ,
dc.identifier.volume40
dc.identifier.issue5
dc.contributor.firstauthorID19625


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster